NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The four year KM stats are locked in stone. Their tertiary endpoints include 1, 2, 3 and 4 year milestone analysis of separation. Not five. In a couple weeks, we will be at 48 months past the 300th patient's initial surgery. 48 months.

Dr. Liau stated at SNO one year milestones should not be used to judge most immunotherapy trials. In two weeks we are five years, five years, past median enrollment, which is Five years + three months past last initial surgery.

LP has stated it was time to validate the data and head to data lock on November 19, 2018 -- which was about six months ago. Six months.

Why are you making arguments for them that they need more maturity, when they have not argued for this themselves?